Скачать или смотреть CSL Restructure SHOCK: Vaccine Unit Spin-Off, 3,000 Job Cuts & Stock Plunge💉😷

Australian biotech giant CSL (CSL.AX) has announced a major restructure — spinning off its vaccine division, cutting 3,000 jobs, and closing 22 blood collection centers. Despite reporting a 14% rise in profit, CSL shares plunged 15%, marking their worst trading day in years.

CEO Paul McKenzie says the move will “reshape and simplify” CSL, saving up to $550M annually by 2026, but investors worry about slower profit growth and earnings pressure.

What does this mean for CSL’s future? Will the vaccine spin-off strengthen its core blood plasma business — or is this a red flag for shareholders?

#CSL #stockmarket #biotech #australia #investing #vaccine #pharmanews #finance #businessnews #csllayoffs #csllayoffs2025 #layoffs #layoffs2025 #covidvaccine #pharmaindustry #startupera #startupera_in #trendingnews